Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins. 2021

Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.

The immunogenicity of the SARS-CoV-2 proteome is largely unknown, especially for non-structural proteins and accessory proteins. In this study, we collect 2,360 COVID-19 sera and 601 control sera. We analyze these sera on a protein microarray with 20 proteins of SARS-CoV-2, building an antibody response landscape for immunoglobulin (Ig)G and IgM. Non-structural proteins and accessory proteins NSP1, NSP7, NSP8, RdRp, ORF3b, and ORF9b elicit prevalent IgG responses. The IgG patterns and dynamics of non-structural/accessory proteins are different from those of the S and N proteins. The IgG responses against these six proteins are associated with disease severity and clinical outcome, and they decline sharply about 20 days after symptom onset. In non-survivors, a sharp decrease of IgG antibodies against S1 and N proteins before death is observed. The global antibody responses to non-structural/accessory proteins revealed here may facilitate a deeper understanding of SARS-CoV-2 immunology.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
January 2021, medRxiv : the preprint server for health sciences,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
August 2023, International journal of molecular sciences,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
January 2023, Immunobiology,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
January 2022, Journal of biomolecular structure & dynamics,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
November 2020, Trends in immunology,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
January 2022, Journal of biomolecular structure & dynamics,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
January 2021, Current protein & peptide science,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
January 2021, Frontiers in immunology,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
June 2024, Microbiology and immunology,
Yang Li, and Zhaowei Xu, and Qing Lei, and Dan-Yun Lai, and Hongyan Hou, and He-Wei Jiang, and Yun-Xiao Zheng, and Xue-Ning Wang, and Jiaoxiang Wu, and Ming-Liang Ma, and Bo Zhang, and Hong Chen, and Caizheng Yu, and Jun-Biao Xue, and Hai-Nan Zhang, and Huan Qi, and Shu-Juan Guo, and Yandi Zhang, and Xiaosong Lin, and Zongjie Yao, and Huiming Sheng, and Ziyong Sun, and Feng Wang, and Xionglin Fan, and Sheng-Ce Tao
January 2020, BioMed research international,
Copied contents to your clipboard!